FDA Risk Evaluation and Mitigation Strategies (REMS) description and effect on generic drug development /
Saved in:
Main Author: | Bodie, Agata, |
---|---|
Other Authors: | Library of Congress. Congressional Research Service, |
Format: | Unknown |
Language: | English |
Published: |
[Washington, D.C.] :
Congressional Research Service,
2018-
|
Physical Description: |
1 online resource. |
Edition: | [Library of Congress public edition]. |
Series: |
CRS report ;
R44810. |
Subjects: | |
Online Access: |
https://purl.fdlp.gov/GPO/gpo114373 |
In Prospector
Similar Items
-
Risk evaluation and mitigation strategies (REMS) and generic drugs
by: Bodie, Agata,
Published: (2018) -
Drug compounding: FDA authority and possible issues for Congress : other title information
by: Bodie, Agata,
Published: (2018) -
How FDA approves drugs and regulates their safety and effectiveness
by: Bodie, Agata,
Published: (2018) -
FDA regulation of over-the-counter (OTC) drugs : overview and issues for Congress
by: Bodie, Agata,
Published: (2021) -
The Food and Drug Administration (FDA) Budget : fact sheet
by: Bodie, Agata,
Published: (2018)